FDA-cleared profile

LVivo Software Application

DiA Imaging Analysis Ltd.

Authorized purpose: Automated echocardiographic LV and RV function, wall-motion and strain, bladder-volume and image-quality measurements for clinician review.

Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.

Product overview

Start with the essentials

Authorized purpose: Automated echocardiographic LV and RV function, wall-motion and strain, bladder-volume and image-quality measurements for clinician review.

Overview status: Source-reviewed overview

Clinical takeaway

Clinical role: Automated echocardiographic LV and RV function, wall-motion and strain, bladder-volume and image-quality measurements for clinician review.

Evidence takeaway

Evidence from the reviewed source record: The exact FDA clinical validation included 170 examinations; among 139 automatically processed examinations, modified WMSI sensitivity was 82%, specificity 79%, accuracy 82%, and Pearson correlation with the reference was 0.89.

Clinical details

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Automated echocardiographic LV and RV function, wall-motion and strain, bladder-volume and image-quality measurements for clinician review.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Intended users
Healthcare professionals interpreting adult echocardiography examinations.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Care setting and population
Adult echocardiography services using DICOM echo examinations.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Workflow role
Automated measurement and wall-motion review aid that requires professional interpretation of the echocardiogram and its outputs.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Required input
Adult echocardiography DICOM clips and standard apical or parasternal views, including 4-chamber, 2-chamber, 3-chamber, short-axis and long-axis views as applicable to the module.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Output and human action
LV and RV function measures, modified wall-motion score index, strain and image-quality outputs, including measurements derived from automatically selected or analyzed echo views.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Limitations
The exact clinical validation used GE and Philips systems at three centers and included 170 examinations; the family GE support article describes additional probe, view-quality and adult-use conditions that are not promoted as exact K243862 labeling.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K243862
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Anatomy
Heart/Cardiovascular
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-03-17
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
The current LVivo family support article describes clinician acceptance and storage of measurements; a Konica Minolta and DiA release describes a family PACS deployment on Exa Cardio PACS, but neither establishes the exact K243862 interface configuration.
  • Public source
  • Product family
  • Checked 2026-09-07
Deployment and data flow
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

Attach an exact-product deployment and data-flow source.

Security and privacy
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-09-07

No current exact-release security attestation was established.

Training and support
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-08-13

Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.

Monitoring and change control
Vendor documentation pending
  • Vendor confirmation
  • Exact FDA submission
  • Checked 2026-08-13

Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.

Clinician acceptance and storage

The GE family support article describes reviewing, accepting and storing the calculated EF result; family details are not asserted as exact K243862 configuration.

product family · checked 2026-09-07

PACS deployment pattern

A Konica Minolta and DiA release describes LVivo family analysis and reporting on Exa Cardio PACS; the release is historical and does not establish current K243862 availability.

product family · checked 2026-09-07

DICOM echo workflow

The exact FDA labeling describes processing adult echocardiography DICOM studies and producing clinician-reviewable measurements.

exact submission · checked 2026-09-06

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The exact FDA clinical validation included 170 examinations; among 139 automatically processed examinations, modified WMSI sensitivity was 82%, specificity 79%, accuracy 82%, and Pearson correlation with the reference was 0.89.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-06
Reported sensitivity
82%
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Reported specificity
82%
  • Public source
  • Exact FDA submission
  • Checked 2026-09-01

Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.

Modified WMSI sensitivity

82 percent

  • EndpointWall-motion score index classification
  • Population139 automatically processed examinations from a 170-examination validation set using GE and Philips systems at 3 centers
  • Tested versionLVivo Software Application release reviewed in K243862

Modified WMSI specificity

79 percent

  • EndpointWall-motion score index classification
  • Population139 automatically processed examinations from a 170-examination validation set using GE and Philips systems at 3 centers
  • Tested versionLVivo Software Application release reviewed in K243862

Modified WMSI Pearson correlation

0.89 correlation

  • EndpointAutomated versus reference wall-motion score index
  • Population139 automatically processed examinations from a 170-examination validation set using GE and Philips systems at 3 centers
  • Tested versionLVivo Software Application release reviewed in K243862

LVivo Software Application modified WMSI validation

  • DesignRetrospective multi-center clinical validation against expert reference
  • PopulationAdult echocardiography examinations from GE and Philips systems at three centers
  • Scopeexact submission
  • Tested versionLVivo Software Application release reviewed in K243862
  • Samplen=170
  • Sites3
  • IndependenceSponsor or vendor study

K243862 FDA 510(k) summary

The FDA summary reports 166 examinations processed and 139 automatically processed for the main analysis.

Costs and setup

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-07

No numeric price was published in the reviewed sources.

Reimbursement and coding
Research pending
  • Needs research
  • Exact FDA submission
  • Checked 2026-08-31

Determine whether any product-specific CPT/HCPCS pathway exists and separate it from billing for the underlying imaging service.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-07Last searched
23Fields reviewed
12Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The stored candidate metadata contained empty PubMed and clinical-trial ID arrays; metadata was screened, not full-text or registry-reviewed. The stored recall candidate record was empty and no event was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, vendor manual, vendor press release, peer reviewed publication, clinical trial registry, recall database, pubmed, clinical trials, openfda device recall

Sources & history

How this profile was documented

Open the ledger for source dates, scope, and research-record updates.

View source ledger and history

Source ledger

  1. K243862 FDA decision source

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, purpose, modality, anatomy

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. LVivo Software Application model card (K243862)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, output, reportedSensitivity, reportedSpecificity, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. FDA 510(k) decision record and summary reviewed for LVivo Software Application, K243862

    U.S. Food and Drug Administration - Published 2025-03-17 - Accessed 2026-09-06

    Scope: identity, intended_use, performance, limitations, implementation

  8. LVivo EF App support article

    GE HealthCare - Accessed 2026-09-07

    Scope: product_family, clinical_workflow, outputs, limitations

  9. Konica Minolta and DiA expand AI-based echocardiography analysis and reporting on Exa Cardio PACS

    Konica Minolta Healthcare Americas and DiA Imaging Analysis - Published 2020-11-10 - Accessed 2026-09-07

    Scope: product_family, PACS_integration, workflow

Research history

  1. K243862 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare